TREATMENT OF SQUAMOUS CELL CARCINOMA WITH HSP27 ANTISENSE OLIGONUCLEOTIDES AND RADIOTHERAPY

摘要

Squamous cell carcinomas, such as squamous head and neck cancer, are treated with a combination of radio-therapy and a therapeutic agent that reduces the amount of hsp27 in the squamous cancer cells. In specific embodiments, the therapeutic agent that reduces the amount of hsp27 is an antisense oligonucleotide therapeutic agent.